Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

Clinical trial NCT01744171 · TERMINATED

Trial details

NCT number: NCT01744171
Sponsor: Roswell Park Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma

Start date: 2013-03-26
Primary completion: 2018-06-11
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.